N
Nora D. Volkow
Researcher at National Institute on Drug Abuse
Publications - 1038
Citations - 121498
Nora D. Volkow is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Dopamine & Addiction. The author has an hindex of 165, co-authored 958 publications receiving 107463 citations. Previous affiliations of Nora D. Volkow include National Institutes of Health & North Shore University Hospital.
Papers
More filters
Journal ArticleDOI
Depressed Dopamine Activity in Caudate and Preliminary Evidence of Limbic Involvement in Adults With Attention-Deficit/Hyperactivity Disorder
Nora D. Volkow,Gene-Jack Wang,Jeffrey H. Newcorn,Frank Telang,Mary V. Solanto,Joanna S. Fowler,Jean Logan,Yeming Ma,Kurt P. Schulz,Kith Pradhan,Christopher Wong,James M. Swanson +11 more
TL;DR: Depressed dopamine activity in caudate and preliminary evidence in limbic regions in adults with ADHD that was associated with inattention and with enhanced reinforcing responses to intravenous methylphenidate suggest that dopamine dysfunction is involved with symptoms of inatt attention but may also contribute to substance abuse comorbidity in ADHD.
Journal ArticleDOI
Inverse Association Between BMI and Prefrontal Metabolic Activity in Healthy Adults
Nora D. Volkow,Gene-Jack Wang,Frank Telang,Joanna S. Fowler,Rita Z. Goldstein,Nelly Alia-Klein,Jean Logan,Christopher Wong,Panayotis K. Thanos,Yemine Ma,Kith Pradhan +10 more
TL;DR: The observed association between higher BMI and lower baseline prefrontal metabolism may underlie the impaired performance reported in healthy obese individuals on some cognitive tests of executive function, and the lack of an association between BMI and brain metabolic activation during cognitive stimulation indicates that BMI does not influence brain glucose utilization during cognitive performance.
Journal ArticleDOI
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up
James M. Swanson,Glen R. Elliott,Laurence L. Greenhill,Timothy Wigal,L. Eugene Arnold,Benedetto Vitiello,Lily Hechtman,Lily Hechtman,Jeffery N. Epstein,William E. Pelham,Howard Abikoff,Jeffrey H. Newcorn,Brooke S. G. Molina,Stephen P. Hinshaw,Karen C. Wells,Betsy Hoza,Peter S. Jensen,Robert D. Gibbons,Kwan Hur,Annamarie Stehli,Mark Davies,John S. March,C. Keith Conners,Mark Caron,Nora D. Volkow +24 more
TL;DR: Stimulant-naïve school-age children with Combined type attention-deficit/hyperactivity disorder were, as a group, larger than expected from norms before treatment but show stimulant-related decreases in growth rates after initiation of treatment, which appeared to reach asymptotes within 3 years without evidence of growth rebound.
Journal ArticleDOI
Overexpression of dopamine D2 receptors reduces alcohol self-administration.
Panayotis K. Thanos,Nora D. Volkow,Paul Freimuth,Hiroyuki Umegaki,Hiroyuki Ikari,George S. Roth,Donald K. Ingram,Robert Hitzemann +7 more
TL;DR: It is shown that increases in DRD2 were associated with marked reductions in alcohol preference, and alcohol intake of ethanol preferring rats, which recovered as theDRD2 returned to baseline levels, suggests that high levels of DRD 2 may be protective against alcohol abuse.
Journal ArticleDOI
Mapping cocaine binding sites in human and baboon brain in vivo.
Joanna S. Fowler,Nora D. Volkow,Alfred P. Wolf,Stephen L. Dewey,David J. Schlyer,Robert R. MacGregor,Robert Hitzemann,Jean Logan,Bernard Bendriem,S. John Gatley,David R. Christman +10 more
TL;DR: The feasibility of using [11C]cocaine and PET to map binding sites for cocaine in human brain, to monitor its kinetics, and to characterize its binding mechanism by using appropriate pharmacological challenges is demonstrated.